When triptans are not an option, gepants can be crucial.

Appeal Your Ubrelvy Denial

Ubrelvy is often denied or heavily restricted, but appeals frequently succeed.

Start Your Appeal
Chat with AI Assistant

Understanding Your Ubrelvy for Acute Migraine Treatment Denial

Ubrelvy is a gepant used acutely to stop migraine attacks. Plans often restrict it to small quantities or deny it unless several triptans have failed.

Common Reasons for Denial

  • ! Insufficient prior triptan trials
  • ! Quantity limits too low for attack frequency
  • ! Use in patients with perceived low migraine burden
  • ! Preference for formulary alternatives

How We Help

We help you document prior acute treatments, contraindications, and attack frequency to justify Ubrelvy at an appropriate quantity.

Start your Ubrelvy appeal.

Some Types of Evidence We Can Use For Supporting Your Appeal

✓ Ubrogepant is effective for acute treatment of migraine and is generally well tolerated.

✓ Gepants provide an option for patients with cardiovascular risk factors that limit triptan use.

✓ Timely acute treatment reduces the need for emergency care and shortens attack duration.

Patient Assistance & Copay Programs

These programs may help reduce your costs while you appeal:

Ubrelvy Savings Card ↗

Pay as little as $0/month with commercial insurance. Up to 13 fills per year.

myAbbVie Assist ↗

Free medication for qualifying patients who have difficulty paying for their medicine.

Eligibility requirements and program terms may change. Please verify current details directly with each organization.

Patient Advocacy & Support Organizations

These organizations provide education, support, and advocacy for patients:

American Migraine Foundation ↗

Leading resource for migraine education, support, and advocacy.

National Headache Foundation ↗

Promotes headache awareness and education, and provides patient resources.

Alliance for Headache Disorders Advocacy ↗

Advocates for equitable policies for people with headache disorders.

Frequently Asked Questions

List all acute meds you’ve tried—over-the-counter and prescription—with responses and side effects. The more thorough, the better.

Yes. If triptans cause side effects, can’t be used often enough, or are unsafe given your risk factors, that still supports coverage for Ubrelvy.

Ready to Fight Your Ubrelvy for Acute Migraine Treatment Denial?

Our free AI-powered tool will help you generate a compelling appeal letter in minutes.

Start Your Appeal Chat with AI Assistant

Disclaimer: Fight Health Insurance is not affiliated with, endorsed by, or partnered with any pharmaceutical manufacturer, healthcare provider, medical device company, or patient assistance program. All information provided is for educational and informational purposes only and does not constitute medical or legal advice. Please consult with your healthcare provider regarding treatment options and with your insurance company regarding coverage decisions.